Your browser doesn't support javascript.
loading
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer.
Ojo, Diane; Wu, Ying; Bane, Anita; Tang, Damu.
Afiliação
  • Ojo D; Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Father Sean O'Sullivan Research Institute, Hamilton, Ontario, Canada; the Hamilton Center for Kidney Research, St. Joseph's Hospital, Hamilton, Ontario, Canada.
  • Wu Y; Department of Pathology and Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada.
  • Bane A; Department of Pathology and Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada.
  • Tang D; Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Father Sean O'Sullivan Research Institute, Hamilton, Ontario, Canada; the Hamilton Center for Kidney Research, St. Joseph's Hospital, Hamilton, Ontario, Canada. Electronic address: damut@mcmaster.ca.
Biochim Biophys Acta Mol Basis Dis ; 1864(3): 735-745, 2018 Mar.
Article em En | MEDLINE | ID: mdl-29248549
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ubiquitinas / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ubiquitinas / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais Idioma: En Ano de publicação: 2018 Tipo de documento: Article